CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,193,310
- in 2 filings, $1.2M under 10b5-1 plans
Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-21 | Ciaramella Giuseppe President and CSO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −69,438 | 20,208 | ||
| 2023-07-21 | Ciaramella Giuseppe President and CSO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −21,846 | 1,457 | ||
| 2023-07-10 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −391 | $30.48 | $12K | 68,917 |
| 2023-06-06 | Burow Kristina Director | Grant or award · Stock Option (Right to Buy) | +16,532 | 16,532 | ||
| 2023-06-06 | COOPER GRAHAM K Director | Grant or award · Stock Option (Right to Buy) | +16,532 | 16,532 | ||
| 2023-06-06 | Fishman Mark Director | Grant or award · Stock Option (Right to Buy) | +16,532 | 16,532 | ||
| 2023-06-06 | Ho Carole Director | Grant or award · Stock Option (Right to Buy) | +16,532 | 16,532 | ||
| 2023-06-06 | MARAGANORE JOHN Director | Grant or award · Stock Option (Right to Buy) | +16,532 | 16,532 | ||
| 2023-04-04 | Evans John M. CEO | Sale 10b5-1 | −6,493 | $29.09 | $189K | 1,117,979 |
| 2023-04-04 | Ciaramella Giuseppe President & CSO | Sale 10b5-1 | −1,754 | $29.09 | $51K | 112,290 |
| 2023-04-04 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −1,161 | $29.09 | $34K | 82,790 |
| 2023-04-04 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −10,493 | $29.77 | $312K | 70,469 |
| 2023-04-04 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −1,161 | $29.09 | $34K | 69,308 |
| 2023-04-04 | Burrell Terry-Ann Chief Financial Officer | Sale 10b5-1 | −2,186 | $29.09 | $64K | 47,117 |
| 2023-04-03 | Evans John M. CEO | Sale 10b5-1 | −5,161 | $30.31 | $156K | 1,124,472 |
| 2023-04-03 | Ciaramella Giuseppe President & CSO | Sale 10b5-1 | −1,918 | $30.31 | $58K | 114,044 |
| 2023-04-03 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −931 | $30.31 | $28K | 83,951 |
| 2023-04-03 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −4,445 | $30.31 | $135K | 80,962 |
| 2023-04-03 | Burrell Terry-Ann Chief Financial Officer | Sale 10b5-1 | −2,454 | $30.31 | $74K | 49,303 |
| 2023-03-31 | Bellon Christine Chief Legal Officer | Grant or award | +17,500 | 84,882 |
Page 11 of 32 · 630 trades